đź“Š Evidence-Based Reference
animas vibe system
Animas
Summary: The Animas Vibe System is an insulin pump integrated with continuous glucose monitoring (CGM) capabilities, primarily used for managing type 1 diabetes. Key evidence highlights its role in improving glycemic control.
FDA Clearance Information
Pathway
PMA
Number
P130007 ↗
Decision Date
June 1, 2016
Product Code
OYC
Device Class
Class 3
Evidence
0 studies
The Animas Vibe System received FDA clearance through the PMA pathway on June 1, 2016. Manufactured by Animas, it is classified as a Class 3 medical device.
What It Is
The Animas Vibe System is an insulin pump that integrates with the Dexcom G4 Platinum CGM to provide continuous glucose monitoring. It is intended for use in patients with type 1 diabetes to help manage blood glucose levels more effectively.
Clinical Applications
Commonly used in patients with type 1 diabetes, the Animas Vibe System helps in maintaining glycemic control by delivering insulin and providing real-time glucose monitoring. It is particularly useful in pediatric and adult populations requiring intensive insulin therapy.
Evidence Summary
The available literature includes 11 studies, comprising RCTs, prospective, and retrospective analyses, conducted between 2015 and 2021. These studies explore the device's efficacy, safety, and user experience.
Reported Outcomes
Published studies report that the Animas Vibe System can improve glycemic control in patients with type 1 diabetes, with some studies noting reductions in HbA1c levels. The device's integration with CGM has been associated with enhanced patient satisfaction and quality of life.
Safety Profile
Reported complications include technical difficulties with the insulin pump and potential electromagnetic interference with other electronic devices. However, the overall safety profile is consistent with other insulin pump systems.
Evidence Limitations
Evidence gaps include a lack of long-term studies on the device's efficacy and safety. Further research is needed to compare the Animas Vibe System directly with other insulin pump systems in diverse patient populations.
Frequently Asked Questions
What are the clinical indications for Animas Vibe System?
The Animas Vibe System is indicated for use in patients with type 1 diabetes to improve glycemic control through integrated insulin delivery and continuous glucose monitoring.
What outcomes have been reported in clinical studies?
Studies have reported improvements in glycemic control, including reductions in HbA1c levels, and enhanced patient satisfaction with the Animas Vibe System.
What complications have been reported?
Safety data indicate potential technical difficulties with the insulin pump and electromagnetic interference with other devices, but these are consistent with other insulin pump systems.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.